These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32036742)

  • 21. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients.
    Zeighami H; Valadkhani F; Shapouri R; Samadi E; Haghi F
    BMC Infect Dis; 2019 Jul; 19(1):629. PubMed ID: 31315572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence and Diversity of Intra- and Interhospital Drug-Resistant and Biofilm-Forming
    Araújo Lima AV; da Silva SM; do Nascimento Júnior JAA; Correia MDS; Luz AC; Leal-Balbino TC; da Silva MV; Lima JLDC; Maciel MAV; Napoleão TH; Oliveira MBM; Paiva PMG
    Microb Drug Resist; 2020 Jul; 26(7):802-814. PubMed ID: 31916896
    [No Abstract]   [Full Text] [Related]  

  • 23. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
    Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
    Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
    Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel compounds against Acinetobacter baumannii 3-oxoacyl-[acyl-carrier-protein] synthase I (FabB) via comprehensive structure-based computational approaches.
    Albayrak E; Koçer S; Mutlu O
    J Mol Graph Model; 2023 Nov; 124():108565. PubMed ID: 37454410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda.
    Kateete DP; Nakanjako R; Okee M; Joloba ML; Najjuka CF
    BMC Res Notes; 2017 Jul; 10(1):284. PubMed ID: 28705201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quorum quenching activity of pentacyclic triterpenoids leads to inhibition of biofilm formation by
    Paul Bhattacharya S; Mitra A; Bhattacharya A; Sen A
    Biofouling; 2020 Sep; 36(8):922-937. PubMed ID: 33103466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates.
    Thummeepak R; Kongthai P; Leungtongkam U; Sitthisak S
    Int Microbiol; 2016 Jun; 19(2):121-129. PubMed ID: 27845499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure based virtual screening and molecular dynamics of natural anti-biofilm compounds against SagS response regulator/sensor kinase in
    Behera SK; Panda AK; Mishra R; Mahanty A; Bisht SS
    J Biomol Struct Dyn; 2023; 41(13):6011-6026. PubMed ID: 35869653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant
    Ranjbar R; Farahani A
    Antimicrob Resist Infect Control; 2019; 8():172. PubMed ID: 31719975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
    Navon-Venezia S; Ben-Ami R; Carmeli Y
    Curr Opin Infect Dis; 2005 Aug; 18(4):306-13. PubMed ID: 15985826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Existence of Biofilm and Biofilm-Associated Virulence Genes in Multi-Drug Resistant Invasive Acinetobacter baumannii Isolates].
    Altınok Ö; Boral B; Ergin A; Eser ÖK
    Mikrobiyol Bul; 2020 Jan; 54(1):40-49. PubMed ID: 32050877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An extensive computational study to identify potential inhibitors of Acyl-homoserine-lactone synthase from Acinetobacter baumannii (strain AYE).
    Jha RK; Jabeer Khan R; Singh E; Kumar A; Jain M; Muthukumaran J; Singh AK
    J Mol Graph Model; 2022 Jul; 114():108168. PubMed ID: 35339024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic strategies against potential antibiofilm targets of multidrug-resistant Acinetobacter baumannii.
    Kaushik V; Tiwari M; Joshi R; Tiwari V
    J Cell Physiol; 2022 Apr; 237(4):2045-2063. PubMed ID: 35083758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Alikhani MY; Bagheri KP
    Microb Pathog; 2017 Jul; 108():122-128. PubMed ID: 28457900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiostrepton Hijacks Pyoverdine Receptors To Inhibit Growth of Pseudomonas aeruginosa.
    Ranieri MRM; Chan DCK; Yaeger LN; Rudolph M; Karabelas-Pittman S; Abdo H; Chee J; Harvey H; Nguyen U; Burrows LL
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262758
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.
    Bahador A; Farshadzadeh Z; Raoofian R; Mokhtaran M; Pourakbari B; Pourhajibagher M; Hashemi FB
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):24. PubMed ID: 29859115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel natural MurD ligase inhibitors as potential antimicrobial agents targeting
    Tiwari P; Sharma P; Kumar M; Kapil A; Abdul Samath E; Kaur P
    J Biomol Struct Dyn; 2022; 40(24):14051-14066. PubMed ID: 34766874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-biofilm and anti-virulence effects of zerumbone against
    Kim HR; Shin DS; Jang HI; Eom YB
    Microbiology (Reading); 2020 Aug; 166(8):717-726. PubMed ID: 32463353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.